About Index Trending news
Analyze
Pricing
Blueprint Medicines

Blueprint Medicines

Work at Blueprint Medicines? Add yourself to this profile

Blueprint Medicines

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers
Edit Profile
More info

Elsewhere

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy Mobile.co Mobile.co HubSpot HubSpot nuTonomy nuTonomy Biogen Biogen Sarepta Therapeutics Sarepta Therapeutics General Catalyst General Catalyst

Companies in the same industry

AirXpanders AirXpanders myMatrixx myMatrixx Veracyte, Inc. Veracyte, Inc. Recombine Recombine Iagnosis Iagnosis Takeda Pharmaceutical Company Ltd Takeda Pharmaceutical Company Ltd NuscriptRX NuscriptRX TriVascular TriVascular Aratana Therapeutics Aratana Therapeutics Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
08 Dec 2016
$125,000,000
Post-IPO debt

Biotech Day on Twitter

Twitter
12 Nov 2014
$50,000,000
Venture capital (Series C)
Redmile Group, RA Capital Management, Wellington Management, +5
07 Jan 2014
$25,000,000
Venture capital (Series B)
Fidelity Biosciences, Third Rock Ventures, Casdin Capital, +2
11 Apr 2011
$40,000,000
Venture capital (Series A)
Fidelity Biosciences, Third Rock Ventures